Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study

V. Frings; F.H.P. van Velden; L.M. Velasquez; W. Hayes; P.M. van de Ven; O.S. Hoekstra; R. Boellaard

doi:10.1148/radiol.14132807

Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study

V. Frings
, F.H.P. van Velden
, L.M. Velasquez
, W. Hayes
, P.M. van de Ven
, O.S. Hoekstra
, R. Boellaard

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	539-548
Journal	Radiology
Volume	273
Issue number	2
DOIs	https://doi.org/10.1148/radiol.14132807
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1148/radiol.14132807

Cite this

@article{8c3ff848ec584ff8892a7cb2af9d2619,

title = "Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study",

author = "V. Frings and \{van Velden\}, F.H.P. and L.M. Velasquez and W. Hayes and \{van de Ven\}, P.M. and O.S. Hoekstra and R. Boellaard",

year = "2014",

doi = "10.1148/radiol.14132807",

language = "Undefined/Unknown",

volume = "273",

pages = "539--548",

journal = "Radiology",

issn = "0033-8419",

publisher = "Radiological Society of North America Inc.",

number = "2",

}

TY - JOUR

T1 - Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study

AU - Frings, V.

AU - van Velden, F.H.P.

AU - Velasquez, L.M.

AU - Hayes, W.

AU - van de Ven, P.M.

AU - Hoekstra, O.S.

AU - Boellaard, R.

PY - 2014

Y1 - 2014

U2 - 10.1148/radiol.14132807

DO - 10.1148/radiol.14132807

M3 - Article

C2 - 24865311

SN - 0033-8419

VL - 273

SP - 539

EP - 548

JO - Radiology

JF - Radiology

IS - 2

ER -